Fagerberg Jonas H, Bergström Christel A S
Department of Pharmacy, Uppsala University, Uppsala Biomedical Centre, PO Box 580, SE-751 23 Uppsala, Sweden.
Ther Deliv. 2015;6(8):935-59. doi: 10.4155/tde.15.45. Epub 2015 Aug 28.
We have explored for which type of compounds biorelevant dissolution profiling in simulated intestinal fluids would accurately predict solubility in human intestinal fluid. In total, 474 solubility values in simulated and aspirated human intestinal fluid for 78 drugs were compiled and analyzed. Significant solubilization in the colloidal structures was obtained in fasted and fed state fluids for drug compounds with a logD(oct)>3. Highly lipophilic compounds with high melting points (Tm > 200 °C) could also be significantly solubilized, but typically such compounds had solubility values in the lower µg/ml range also in the presence of the colloidal structures. On the basis of our analysis, compounds with a logD(oct)>3 should be explored in biorelevant dissolution media to better predict in vivo performance after oral dosing.
我们已经探究了在模拟肠液中哪种类型的化合物的生物相关性溶出曲线能够准确预测其在人体肠液中的溶解度。总共收集并分析了78种药物在模拟和抽取的人体肠液中的474个溶解度值。对于logD(辛醇)>3的药物化合物,在禁食和进食状态的肠液中,其在胶体结构中实现了显著增溶。具有高熔点(Tm>200°C)的高亲脂性化合物也能够显著增溶,但通常这类化合物在存在胶体结构的情况下,其溶解度值也处于较低的μg/ml范围内。基于我们的分析,对于logD(辛醇)>3的化合物,应在生物相关性溶出介质中进行研究,以更好地预测口服给药后的体内性能。